ADENTRA Inc. (TSE:ADEN) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of ADENTRA Inc. (TSE:ADENGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company.

A number of brokerages recently weighed in on ADEN. Canadian Imperial Bank of Commerce raised their price objective on ADENTRA from C$41.00 to C$42.00 in a report on Tuesday, November 11th. Raymond James Financial lifted their price target on shares of ADENTRA from C$43.00 to C$46.00 in a research note on Tuesday, November 11th. Scotiabank upped their price objective on shares of ADENTRA from C$41.00 to C$46.00 in a research note on Thursday, January 29th. Stifel Nicolaus increased their target price on shares of ADENTRA from C$47.00 to C$51.00 and gave the company a “buy” rating in a report on Friday, February 6th. Finally, National Bank Financial boosted their price target on shares of ADENTRA from C$42.50 to C$54.50 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th.

Get Our Latest Report on ADEN

ADENTRA Stock Down 0.2%

Shares of ADEN stock opened at $39.90 on Wednesday. The business has a 50-day moving average price of $36.34 and a two-hundred day moving average price of $34.78. ADENTRA has a 12-month low of $24.60 and a 12-month high of $41.20. The firm has a market cap of $966.26 million, a P/E ratio of 22.67 and a beta of 1.56.

About ADENTRA

(Get Free Report)

Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.

Recommended Stories

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.